RELATED CONTENT
NEWS
- Celgene to acquire Avila Therapeutics for $350m plus $575m in milestones
- Merrimack still ambitious for IPO as others wait in the wings
- Cancer developer Merrimack dives into a tough IPO pool with a $172M filing
- Third time's the charm for $100 million Merrimack IPO after two false starts
ANALYSIS
Other Informa Analysis
EVENTS
Today
Le Plaza Hotel, Brussels, Belgium
Today
Diplomat Hotel, Prague, Czech Republic
Today
Business Design Centre, London
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

